Haploid Allogeneic Transplant Using the CliniMACS System

Clinical trial NCT00185679 · TERMINATED

Trial details

NCT number: NCT00185679
Sponsor: Ginna Laport
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myelogenous Leukemia (AML) - Relapsed, Primary Refractory Disease or Poor Risk Factors Chronic Myelogenous Leukemia (CML) - Accelerated or Second Chronic Phase Myelodysplastic Syndrome (MDS) - High and Intermediate Risk Non-Hodgkin's Lymphoma (NHL)Chronic Lymphocytic Leukemia (CLL) - Refractory

Start date: 2001-11-01
Primary completion: 2009-10-01
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.